In all fields of medicine, major efforts are currently dedicated to improve the clinical, physiological and therapeutic understanding of disease, and obstructive sleep apnoea (OSA) is no exception. The personalised medicine approach is relevant for OSA, given its complex pathophysiology and variable clinical presentation, the interactions with comorbid conditions and its possible contribution to poor outcomes. Treatment with continuous positive airway pressure (CPAP) is effective, but CPAP is poorly tolerated or not accepted in a considerable proportion of OSA patients. This review summarises the available studies on the physiological phenotypes of upper airway response to obstruction during sleep, and the clinical presentations of OSA (phenotypes and clusters) with a special focus on our changing attitudes towards approaches to treatment. Such major efforts are likely to change and expand treatment options for OSA beyond the most common current choices (i.e. CPAP, mandibular advancement devices, positional treatment, lifestyle changes or upper airway surgery). More importantly, treatment for OSA may become more effective, being tailored to each patient’s need.

Bonsignore MR, S.G.M. (2017). Personalized medicine in sleep respiratory disorders; focus on OSA diagnosis and treatment. EUROPEAN RESPIRATORY REVIEW, 26(146), 00-00 [10.1183/16000617.0069-2017].

Personalized medicine in sleep respiratory disorders; focus on OSA diagnosis and treatment.

Bonsignore MR
;
2017-01-01

Abstract

In all fields of medicine, major efforts are currently dedicated to improve the clinical, physiological and therapeutic understanding of disease, and obstructive sleep apnoea (OSA) is no exception. The personalised medicine approach is relevant for OSA, given its complex pathophysiology and variable clinical presentation, the interactions with comorbid conditions and its possible contribution to poor outcomes. Treatment with continuous positive airway pressure (CPAP) is effective, but CPAP is poorly tolerated or not accepted in a considerable proportion of OSA patients. This review summarises the available studies on the physiological phenotypes of upper airway response to obstruction during sleep, and the clinical presentations of OSA (phenotypes and clusters) with a special focus on our changing attitudes towards approaches to treatment. Such major efforts are likely to change and expand treatment options for OSA beyond the most common current choices (i.e. CPAP, mandibular advancement devices, positional treatment, lifestyle changes or upper airway surgery). More importantly, treatment for OSA may become more effective, being tailored to each patient’s need.
2017
Settore MED/10 - Malattie Dell'Apparato Respiratorio
Bonsignore MR, S.G.M. (2017). Personalized medicine in sleep respiratory disorders; focus on OSA diagnosis and treatment. EUROPEAN RESPIRATORY REVIEW, 26(146), 00-00 [10.1183/16000617.0069-2017].
File in questo prodotto:
File Dimensione Formato  
BonsignoreERRpersonalizedmedicinesleep2017.pdf

accesso aperto

Dimensione 428.89 kB
Formato Adobe PDF
428.89 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/274777
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 49
social impact